Larimar Therapeutics (LRMR) Balance Sheet: Assets & Liabilities

Larimar Therapeutics (LRMR) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Larimar Therapeutics reported total assets of $145.84M and total liabilities of $67.76M. Shareholders' equity was $78.08M, down 54.6% from $171.81M a year earlier. Total debt stood at $4.07M against $136.85M in cash and short-term investments, a net cash position of $132.78M. That puts debt-to-equity at 0.05, compared with 0.03 a year earlier.

Larimar Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Larimar Therapeutics, Inc. (LRMR) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	85.41	33.22	26.75	26.83	70.10	68.15	1.01	49.33	40.78
Short-Term Investments	51.44	150.24	60.04	91.60	0.00	24.49	0.00	68.74	61.28
Cash & Short-Term Investments	136.85	183.45	86.79	118.43	70.10	92.64	1.01	118.07	102.05
Accounts Receivable	0.75	1.05	0.33	0.00	0.21	0.03	0.16	1.54	0.95
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	4.42	0.52	3.39	2.31	0.28	5.28	3.58	2.17	1.93
Total Current Assets	142.02	195.30	90.18	120.74	72.20	97.95	4.75	121.33	104.93
Non-Current Assets
Property, Plant & Equipment (Net)	2.69	3.72	3.76	3.69	4.46	4.98	0.36	0.38	0.53
Long-Term Investments	0.00	0.00	1.34	0.00	1.34	0.00	0.00	0.00	0.00
Other Non-Current Assets	1.13	1.20	2.00	1.98	2.01	1.76	0.09	0.06	0.06
Total Non-Current Assets	3.82	4.92	5.76	5.67	6.46	6.73	0.45	0.43	0.59
Total Assets	145.84	200.23	95.94	126.41	78.67	104.69	5.20	121.76	105.51
Current Liabilities
Accounts Payable	5.22	2.42	1.28	1.69	1.66	2.63	3.54	0.91	0.00
Short-Term Debt	1.11	1.06	0.84	0.61	0.59	0.52	0.10	5.46	0.00
Accrued Liabilities	58.47	20.87	7.39	8.41	6.59	5.84	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-5.46	0.00
Other Current Liabilities	58.47	20.87	7.39	8.41	6.59	5.84	2.26	6.94	4.27
Total Current Liabilities	64.80	24.36	9.51	10.71	8.85	8.99	5.90	13.31	7.29
Non-Current Liabilities
Long-Term Debt	2.96	4.06	4.71	4.80	5.41	6.00	0.00	15.19	20.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	2.96	4.06	4.71	4.80	5.41	6.00	0.00	15.19	20.00
Total Liabilities	67.76	28.41	14.22	15.50	14.25	14.99	5.90	28.49	27.29
Stockholders' Equity
Common Stock	0.08	0.06	0.04	0.04	0.02	0.02	0.01	0.04	0.03
Retained Earnings	-434.83	-269.16	-188.55	-151.61	-116.25	-65.61	-23.13	-350.95	-289.58
Accumulated Other Comprehensive Income	0.05	0.15	0.08	-0.03	0.00	0.00	0.00	-0.03	-0.06
Additional Paid-in Capital	512.78	440.76	270.15	262.50	180.65	155.29	22.43	444.21	367.83
Shares Outstanding	83.09	63.82	43.91	43.27	17.71	-	-	-	-
Total Stockholders' Equity	78.09	171.81	81.72	110.90	64.41	89.69	-0.69	93.27	78.22
Total Liabilities & Equity	145.84	200.23	95.94	126.41	78.67	104.69	5.20	121.76	105.51

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Larimar Therapeutics Balance Sheet

How much debt does Larimar Therapeutics have?

Larimar Therapeutics had total debt of $4.07M as of Dec 31, 2025, against $136.85M in cash and short-term investments. Its debt-to-equity ratio was 0.05. Total debt was $5.12M a year earlier.

What are Larimar Therapeutics's total assets?

Larimar Therapeutics reported total assets of $145.84M as of Dec 31, 2025, down 27.2% from $200.22M a year earlier. Total liabilities were $67.76M.

What is Larimar Therapeutics's shareholders' equity?

Larimar Therapeutics's shareholders' equity was $78.08M as of Dec 31, 2025, or about $0.94 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition